Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients — Stella

Home/Radiation Induced Fibrosis/

View on ClinicalTrials.gov

Recruiting

Back to Radiation Induced Fibrosis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Vail Health Shaw Cancer Center, Edwards, Colorado

Key details

Phase

Safety & dosing

Sponsor

Shaw Cancer Center

Collaborators

Steadman Philippon Research Institute

Enrollment target

~40 participants

Started

August 2023

Primary completion

August 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years and older

Sex

Female only

Last updated September 2024